Antithrombin Therapy for Severe PreeclampsiaMasahiro Maki, Toshihiko Terao, Tsuyomu Ikenoue et al.|Thrombosis and Haemostasis|2000Cited by 54
Antithrombin therapy for severe preeclampsia: results of a double-blind, randomized, placebo-controlled trial. BI51.017 Study Group.Masahiro Maki, M Urata, Takao Kobayashi et al.|PubMed|2000Cited by 51
Pulmonary Thromboembolism in Obstetrics and Gynecology Increased by 6.5-Fold Over the Past Decade in JapanTakao Kobayashi, Tsuyomu Ikenoue, Masao Nakabayashi et al.|Circulation Journal|2008Cited by 43
The Relationship between Clinical Signs and Hypercoagulable State in Toxemia of PregnancyToshihiko Terao, Hiroshi Sameshima, Masahiro Maki et al.|Gynecologic and Obstetric Investigation|2010Cited by 35
Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in JapanTakao Kobayashi, Tsuyomu Ikenoue, Masao Nakabayashi et al.|International Journal of Hematology|2011Cited by 34